ClinMed Pharma

Integrated solutions to optimise success

In our capacity as a purpose-driven organisation we have been very keen to support organisations with acquiring the orphan designation in Europe and the US. Our epidemiologists work very closely with our regulatory team to review all available data and complete the regulatory application for designation.

With the market exclusivity associated with orphan indications we have an inclusive integrated solutions to optimise success of projects in adult and paediatric populations.

Rare and orphan disease

Therapeutic Area Expertise

Request for information

Learn more

Request for proposal

Learn more